Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CLS006 versus vehicle in subjects aged 2 years and older with cutaneous common warts has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Warts
• Cutaneous Warts

Drugs mentioned

• CLS006

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Cutaneous Common Warts | Phase 3 | Status: COMPLETED | Results posted: 2023-09-14